Q8VE98 (CD276_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 98.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: CD276 antigen Alternative name(s): B7 homolog 3 Short name=B7-H3 Costimulatory molecule CD_antigen=CD276 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 316 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Modulates T-cell-mediated immune responses and the development of acute and chronic transplant rejection. Plays a positive regulatory role in bone formation and has a dual role in the bone-immune interface. Induces antitumor immunity as it activates both acquired and innate immunity leading to natural killer cell and CD8 T-cell dependent killing of tumor cells. Ref.1 Ref.2 Ref.6 Ref.7 Ref.8 |
| Subunit structure | Interacts with TREML2 and this interaction enhances T-cell activation By similarity. |
| Subcellular location | Membrane; Single-pass type I membrane protein Probable. |
| Tissue specificity | Ubiquitous. Ref.1 |
| Developmental stage | Highly expressed in developing bones during embryogenesis and expression increases as osteoblast precursor cells differentiate into mature osteoblasts. Ref.2 |
| Induction | Up-regulated in cells mediating rejection of mouse transplant. Ref.8 |
| Disruption phenotype | Mice display a lower bone mineral density in cortical bones with femurs more susceptible to bone fracture, but do not exhibit any important skeletal abnormalities. Calvarial cells reveal normal number of osteoblast precursor cells with adequate proliferative capacity, but have impaired osteogenic differentiation. Furthermore, following cardiac transplantation, they display permanent survival under rapamycin regimen and cardiac transplants also show markedly decreased production of key cytokine and chemokine. The incidence of chronic transplant rejection is also inhibited. Mice also develop more severe airway inflammation and experimental autoimmune encephalomyelitis earlier than wild-type littermates as well as accumulate higher concentrations of autoantibodies to DNA. Ref.2 |
| Miscellaneous | Gene transfer of B7-H3 leads to complete regression of 50 per cent tumors, or significantly slows tumor growth. In primates, B7-H3 locus underwent genomic duplication leading to tandemly repeated immunoglobulin-like V and C domains (VC domains). The dominantly expressed human B7-H3 isoform contains tandemly duplicated VC domains. In contrast, mouse B7-H3 transcript contains only one single VC domain form due to an exon structure corresponding to V domain-(pseudoexon C)-(pseudoexon V)-C domain. This duplication appearing in primates is suggested to be very recent supporting a model of multiple independent emergence of tandem VC repeats within human and monkey species. |
| Sequence similarities | Belongs to the immunoglobulin superfamily. BTN/MOG family. Contains 1 Ig-like C2-type (immunoglobulin-like) domain. Contains 1 Ig-like V-type (immunoglobulin-like) domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | Potential | |||||||||||||||||||||||||||||||||||||||
| Chain | 29 – 316 | 288 | CD276 antigen | PRO_0000045802 | ||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 29 – 248 | 220 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||||
| Transmembrane | 249 – 269 | 21 | Helical; Potential | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 270 – 316 | 47 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||
| Domain | 29 – 139 | 111 | Ig-like V-type | |||||||||||||||||||||||||||||||||||||||
| Domain | 145 – 238 | 94 | Ig-like C2-type | |||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 104 | 1 | N-linked (GlcNAc...) Ref.9 Ref.10 | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 189 | 1 | N-linked (GlcNAc...) Ref.9 Ref.10 | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 197 | 1 | N-linked (GlcNAc...) Ref.9 | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 215 | 1 | N-linked (GlcNAc...) Ref.10 | |||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 165 ↔ 220 | By similarity | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 46 – 48 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 60 – 62 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 63 – 69 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 70 – 72 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 75 – 80 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 83 – 89 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 97 – 99 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 100 – 102 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 107 – 109 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 114 – 116 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 120 – 126 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 146 – 148 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 159 – 172 | 14 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 175 – 179 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 188 – 196 | 9 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 202 – 211 | 10 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 217 – 224 | 8 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 225 – 228 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 229 – 236 | 8 | ||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Characterization of mouse and human B7-H3 genes." Sun M., Richards S., Prasad D.V., Mai X.M., Rudensky A., Dong C. J. Immunol. 168:6294-6297(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY. |
| [2] | "The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses." Suh W.-K., Gajewska B.U., Okada H., Gronski M.A., Bertram E.M., Dawicki W., Duncan G.S., Bukczynski J., Plyte S., Elia A., Wakeham A., Itie A., Chung S., Da Costa J., Arya S., Horan T., Campbell P., Gaida K. Mak T.W.Nat. Immunol. 4:899-906(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE. Strain: C57BL/6. |
| [3] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: NOD. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: FVB/N. Tissue: Colon and Mammary tumor. |
| [5] | "Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss." Ling V., Wu P.W., Spaulding V., Kieleczawa J., Luxenberg D., Carreno B.M., Collins M. Genomics 82:365-377(2003) [PubMed] [Europe PMC] [Abstract] Cited for: GENOMIC DOMAIN DUPLICATION. |
| [6] | "Mouse B7-H3 induces antitumor immunity." Sun X., Vale M., Leung E., Kanwar J.R., Gupta R., Krissansen G.W. Gene Ther. 10:1728-1734(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, GENE TRANSFER. |
| [7] | "Murine B7-H3 is a negative regulator of T cells." Prasad D.V., Nguyen T., Li Z., Yang Y., Duong J., Wang Y., Dong C. J. Immunol. 173:2500-2506(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [8] | "B7-H3 promotes acute and chronic allograft rejection." Wang L., Fraser C.C., Kikly K., Wells A.D., Han R., Coyle A.J., Chen L., Hancock W.W. Eur. J. Immunol. 35:428-438(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INDUCTION. |
| [9] | "The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation." Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B. Mol. Cell. Proteomics 8:2555-2569(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-104; ASN-189 AND ASN-197, MASS SPECTROMETRY. Tissue: Myoblast. |
| [10] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-104; ASN-189 AND ASN-215, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AY190318 mRNA. Translation: AAP04007.1. AK155114 mRNA. Translation: BAE33058.1. BC019436 mRNA. Translation: AAH19436.1. BC056608 mRNA. Translation: AAH56608.1. | ||||||||||||
| IPI | IPI00124078. | ||||||||||||
| RefSeq | NP_598744.1. NM_133983.4. | ||||||||||||
| UniGene | Mm.5356. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q8VE98. | ||||||||||||
| SMR | Q8VE98. Positions 35-239. | ||||||||||||
| ModBase | Search... | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q8VE98. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q8VE98. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUST00000039788; ENSMUSP00000042681; ENSMUSG00000035914. ENSMUST00000165365; ENSMUSP00000129418; ENSMUSG00000035914. | ||||||||||||
| GeneID | 102657. | ||||||||||||
| KEGG | mmu:102657. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 80381. | ||||||||||||
| MGI | MGI:2183926. Cd276. | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG85729. | ||||||||||||
| GeneTree | ENSGT00700000104325. | ||||||||||||
| HOGENOM | HOG000293131. | ||||||||||||
| HOVERGEN | HBG079786. | ||||||||||||
| InParanoid | Q8VE98. | ||||||||||||
| KO | K06746. | ||||||||||||
| OMA | ETHASVT. | ||||||||||||
| OrthoDB | EOG4PC9T7. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q8VE98. | ||||||||||||
| Bgee | Q8VE98. | ||||||||||||
| CleanEx | MM_CD276. | ||||||||||||
| Genevestigator | Q8VE98. | ||||||||||||
| GermOnline | ENSMUSG00000035914. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 2 hits. | ||||||||||||
| InterPro | IPR013162. CD80_C2-set. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR013106. Ig_V-set. [Graphical view] | ||||||||||||
| Pfam | PF08205. C2-set_2. 1 hit. PF07686. V-set. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00409. IG. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50835. IG_LIKE. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 355600. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CD276_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q8VE98 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
